The structural heart imaging market size has grown strongly in recent years. It will grow from $17.09 billion in 2025 to $18.75 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increasing prevalence of structural heart diseases, expansion of transcatheter cardiac procedures, advancements in echocardiography and CT imaging, growing use of imaging in interventional cardiology, rising adoption of catheter-based therapies.
The structural heart imaging market size is expected to see strong growth in the next few years. It will grow to $27.02 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac interventions, growing investments in smart cardiac imaging platforms, expansion of ai-assisted diagnostic imaging, rising use of imaging for complex valve procedures, increasing focus on procedural outcome optimization. Major trends in the forecast period include increasing adoption of real-time image-guided cardiac interventions, rising use of advanced multimodality imaging systems, growing integration of ai-based image analysis, expansion of 3D and 4D cardiac visualization technologies, enhanced focus on pre-procedural planning accuracy.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart imaging market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including heart attacks, strokes, and hypertension. The rise in these conditions is largely attributed to unhealthy lifestyles, such as poor diet, physical inactivity, and smoking, which contribute to obesity, hypertension, and diabetes. Structural heart imaging supports the management of cardiovascular diseases by providing detailed and accurate diagnostic images, making it particularly useful for detecting heart valve abnormalities and congenital defects. It also enhances treatment outcomes by enabling early intervention and precise procedural guidance. For example, in January 2024, the American Heart Association, a U.S.-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, a 4% increase from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the structural heart imaging market.
Leading companies in the structural heart imaging market are focusing on technological advancements, including the development of artificial intelligence (AI)-driven ultrasound systems. These AI-powered ultrasound systems are cutting-edge imaging technologies that integrate artificial intelligence to improve image quality, automate measurements, and assist in real-time diagnostic decision-making. For example, in October 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched its AI-powered Venue Family point-of-care ultrasound systems, featuring a caption guidance feature. These systems enhance structural heart imaging by automating cardiac assessments, optimizing image quality, and providing real-time Doppler analysis. Their portability enables rapid diagnosis and accurate evaluation of valvular and structural heart conditions in critical care and procedural settings.
In February 2025, Medtronic plc, an Ireland-based medical device company specializing in cardiac and vascular solutions, formed a partnership with Koninklijke Philips N.V. to advance cardiac computed tomography (CT), magnetic resonance imaging (MRI), and interventional imaging. Through this collaboration, the companies aim to train over 300 clinicians in India on advanced structural heart imaging techniques, enhancing diagnostic accuracy and improving procedural outcomes in the treatment of structural heart diseases. Koninklijke Philips N.V., based in the Netherlands, provides a comprehensive range of structural heart imaging technologies, including echocardiography, cardiac CT, MRI, and interventional imaging solutions.
Major companies operating in the structural heart imaging market are Hitachi Medical Corporation, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Boston Scientific Corporation, Edwards Lifesciences, Shimadzu Corporation, Esaote SpA, Canon Medical Systems Corporation, Circle Cardiovascular Imaging Inc., Pie Medical Imaging B.V., Arineta Ltd, Samsung Medison, United Imaging Healthcare, Bracco Imaging S.p.A., Siemens Medical Solutions USA Inc., Toshiba Medical Systems Corporation.
North America was the largest region in the structural heart imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural heart imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the structural heart imaging market by increasing costs of imported imaging hardware, high-resolution sensors, software platforms, and advanced computing components. Cardiac centers in North America and Europe are most affected due to reliance on imported imaging systems, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital expenditure requirements for healthcare providers. However, they are also encouraging local assembly, regional software development, and innovation in cost-optimized cardiac imaging solutions.
The structural heart imaging market research report is one of a series of new reports that provides structural heart imaging market statistics, including structural heart imaging industry global market size, regional shares, competitors with a structural heart imaging market share, detailed structural heart imaging market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart imaging industry. This structural heart imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural heart imaging is a form of medical imaging that provides detailed, high-quality images of the heart’s structure, including its valves, walls, and chambers. This imaging helps physicians detect and assess issues such as valve abnormalities or heart defects. It is commonly used for pre-procedural planning, real-time guidance during procedures, and post-treatment monitoring.
The key procedures in the structural heart imaging market include transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage closure (LAAC), and patent foramen ovale (PFO) closure. TAVI is a minimally invasive procedure designed to replace a narrowed aortic valve (aortic stenosis) without the need for traditional open-heart surgery. The imaging technologies used in these procedures include transesophageal echocardiography (TEE), intravascular ultrasound (IVUS), fluoroscopy, cardiac magnetic resonance imaging (CMRI), and computed tomography (CT). Vendors in this market are divided into original equipment manufacturers (OEMs) and third-party providers. The main applications of structural heart imaging include diagnosis and surgical interventions, while its end-users are hospitals, specialty clinics, cardiac centers, diagnostic centers, ambulatory surgical centers, catheterization labs, and other healthcare facilities.
The structural heart imaging market consists of revenues earned by entities by providing services such as fusion imaging, three-dimensional (3D) and four-dimensional (4D) imaging solutions, artificial intelligence (AI)-enabled cardiac imaging analysis and hybrid or intraoperative imaging for minimally invasive heart procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart imaging market also includes sales of photoacoustic imaging (PAI), augmented reality (AR) and virtual reality (VR)-integrated imaging, image-guided intervention tools and endoscopic cardiac imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The structural heart imaging market size is expected to see strong growth in the next few years. It will grow to $27.02 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiac interventions, growing investments in smart cardiac imaging platforms, expansion of ai-assisted diagnostic imaging, rising use of imaging for complex valve procedures, increasing focus on procedural outcome optimization. Major trends in the forecast period include increasing adoption of real-time image-guided cardiac interventions, rising use of advanced multimodality imaging systems, growing integration of ai-based image analysis, expansion of 3D and 4D cardiac visualization technologies, enhanced focus on pre-procedural planning accuracy.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart imaging market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including heart attacks, strokes, and hypertension. The rise in these conditions is largely attributed to unhealthy lifestyles, such as poor diet, physical inactivity, and smoking, which contribute to obesity, hypertension, and diabetes. Structural heart imaging supports the management of cardiovascular diseases by providing detailed and accurate diagnostic images, making it particularly useful for detecting heart valve abnormalities and congenital defects. It also enhances treatment outcomes by enabling early intervention and precise procedural guidance. For example, in January 2024, the American Heart Association, a U.S.-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, a 4% increase from 224.4 per 100,000 in 2023. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the structural heart imaging market.
Leading companies in the structural heart imaging market are focusing on technological advancements, including the development of artificial intelligence (AI)-driven ultrasound systems. These AI-powered ultrasound systems are cutting-edge imaging technologies that integrate artificial intelligence to improve image quality, automate measurements, and assist in real-time diagnostic decision-making. For example, in October 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched its AI-powered Venue Family point-of-care ultrasound systems, featuring a caption guidance feature. These systems enhance structural heart imaging by automating cardiac assessments, optimizing image quality, and providing real-time Doppler analysis. Their portability enables rapid diagnosis and accurate evaluation of valvular and structural heart conditions in critical care and procedural settings.
In February 2025, Medtronic plc, an Ireland-based medical device company specializing in cardiac and vascular solutions, formed a partnership with Koninklijke Philips N.V. to advance cardiac computed tomography (CT), magnetic resonance imaging (MRI), and interventional imaging. Through this collaboration, the companies aim to train over 300 clinicians in India on advanced structural heart imaging techniques, enhancing diagnostic accuracy and improving procedural outcomes in the treatment of structural heart diseases. Koninklijke Philips N.V., based in the Netherlands, provides a comprehensive range of structural heart imaging technologies, including echocardiography, cardiac CT, MRI, and interventional imaging solutions.
Major companies operating in the structural heart imaging market are Hitachi Medical Corporation, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Fujifilm Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Boston Scientific Corporation, Edwards Lifesciences, Shimadzu Corporation, Esaote SpA, Canon Medical Systems Corporation, Circle Cardiovascular Imaging Inc., Pie Medical Imaging B.V., Arineta Ltd, Samsung Medison, United Imaging Healthcare, Bracco Imaging S.p.A., Siemens Medical Solutions USA Inc., Toshiba Medical Systems Corporation.
North America was the largest region in the structural heart imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural heart imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the structural heart imaging market by increasing costs of imported imaging hardware, high-resolution sensors, software platforms, and advanced computing components. Cardiac centers in North America and Europe are most affected due to reliance on imported imaging systems, while Asia-Pacific faces pricing pressure on equipment manufacturing and exports. These tariffs are increasing capital expenditure requirements for healthcare providers. However, they are also encouraging local assembly, regional software development, and innovation in cost-optimized cardiac imaging solutions.
The structural heart imaging market research report is one of a series of new reports that provides structural heart imaging market statistics, including structural heart imaging industry global market size, regional shares, competitors with a structural heart imaging market share, detailed structural heart imaging market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart imaging industry. This structural heart imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural heart imaging is a form of medical imaging that provides detailed, high-quality images of the heart’s structure, including its valves, walls, and chambers. This imaging helps physicians detect and assess issues such as valve abnormalities or heart defects. It is commonly used for pre-procedural planning, real-time guidance during procedures, and post-treatment monitoring.
The key procedures in the structural heart imaging market include transcatheter aortic valve implantation (TAVI), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage closure (LAAC), and patent foramen ovale (PFO) closure. TAVI is a minimally invasive procedure designed to replace a narrowed aortic valve (aortic stenosis) without the need for traditional open-heart surgery. The imaging technologies used in these procedures include transesophageal echocardiography (TEE), intravascular ultrasound (IVUS), fluoroscopy, cardiac magnetic resonance imaging (CMRI), and computed tomography (CT). Vendors in this market are divided into original equipment manufacturers (OEMs) and third-party providers. The main applications of structural heart imaging include diagnosis and surgical interventions, while its end-users are hospitals, specialty clinics, cardiac centers, diagnostic centers, ambulatory surgical centers, catheterization labs, and other healthcare facilities.
The structural heart imaging market consists of revenues earned by entities by providing services such as fusion imaging, three-dimensional (3D) and four-dimensional (4D) imaging solutions, artificial intelligence (AI)-enabled cardiac imaging analysis and hybrid or intraoperative imaging for minimally invasive heart procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The structural heart imaging market also includes sales of photoacoustic imaging (PAI), augmented reality (AR) and virtual reality (VR)-integrated imaging, image-guided intervention tools and endoscopic cardiac imaging. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Structural Heart Imaging Market Characteristics
3. Structural Heart Imaging Market Supply Chain Analysis
4. Global Structural Heart Imaging Market Trends and Strategies
5. Structural Heart Imaging Market Analysis of End Use Industries
7. Global Structural Heart Imaging Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Structural Heart Imaging Total Addressable Market (TAM) Analysis for the Market
9. Structural Heart Imaging Market Segmentation
10. Structural Heart Imaging Market Regional and Country Analysis
11. Asia-Pacific Structural Heart Imaging Market
12. China Structural Heart Imaging Market
13. India Structural Heart Imaging Market
14. Japan Structural Heart Imaging Market
15. Australia Structural Heart Imaging Market
16. Indonesia Structural Heart Imaging Market
17. South Korea Structural Heart Imaging Market
18. Taiwan Structural Heart Imaging Market
19. South East Asia Structural Heart Imaging Market
20. Western Europe Structural Heart Imaging Market
21. UK Structural Heart Imaging Market
22. Germany Structural Heart Imaging Market
23. France Structural Heart Imaging Market
24. Italy Structural Heart Imaging Market
25. Spain Structural Heart Imaging Market
26. Eastern Europe Structural Heart Imaging Market
27. Russia Structural Heart Imaging Market
28. North America Structural Heart Imaging Market
29. USA Structural Heart Imaging Market
30. Canada Structural Heart Imaging Market
31. South America Structural Heart Imaging Market
32. Brazil Structural Heart Imaging Market
33. Middle East Structural Heart Imaging Market
34. Africa Structural Heart Imaging Market
36. Structural Heart Imaging Market Competitive Landscape and Company Profiles
37. Structural Heart Imaging Market Other Major and Innovative Companies
40. Structural Heart Imaging Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Structural Heart Imaging Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses structural heart imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for structural heart imaging? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural heart imaging market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Procedure Type: Transcatheter Aortic Valve Implantation (TAVI); Transcatheter Mitral Valve Replacement (TMVR); Transcatheter Tricuspid Valve Replacement (TTVR); Left Atrial Appendage Closure (LAAC); Patent Foramen Ovale (PFO) Closure2) By Imaging Modality: Transesophageal Echocardiography (TEE); Intravascular Ultrasound (IVUS); Fluoroscopy; Cardiac Magnetic Resonance Imaging (CMRI); Computed Tomography (CT)
3) By Vendor Type: Original Equipment Manufacturers (OEMs); Third-Party Vendors
4) By Applications: Diagnosis; Surgery
5) By End-User: Hospitals; Specialty Clinics; Cardiac Centers; Diagnostic Centers; Ambulatory Surgical Centers; Catheterization Laboratories; Other End-Users
Subsegments:
1) By Transcatheter Aortic Valve Implantation (TAVI): Balloon-Expandable Valves; Self-Expanding Valves2) By Transcatheter Mitral Valve Replacement (TMVR): Mechanical Valves; Bioprosthetic Valves
3) By Transcatheter Tricuspid Valve Replacement (TTVR): Catheter-Based Approaches; Percutaneous Annuloplasty
4) By Left Atrial Appendage Closure (LAAC): Endocardial Closure Devices; Epicardial Closure Devices
5) By Patent Foramen Ovale (PFO) Closure: Occluder Devices; Suture-Based Devices
Companies Mentioned: Hitachi Medical Corporation; Abbott Laboratories; Medtronic plc; Siemens Healthineers; Fujifilm Holdings Corporation; GE Healthcare; Koninklijke Philips N.V.; Boston Scientific Corporation; Edwards Lifesciences; Shimadzu Corporation; Esaote SpA; Canon Medical Systems Corporation; Circle Cardiovascular Imaging Inc.; Pie Medical Imaging B.V.; Arineta Ltd; Samsung Medison; United Imaging Healthcare; Bracco Imaging S.p.A.; Siemens Medical Solutions USA Inc.; Toshiba Medical Systems Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Structural Heart Imaging market report include:- Hitachi Medical Corporation
- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers
- Fujifilm Holdings Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Boston Scientific Corporation
- Edwards Lifesciences
- Shimadzu Corporation
- Esaote SpA
- Canon Medical Systems Corporation
- Circle Cardiovascular Imaging Inc.
- Pie Medical Imaging B.V.
- Arineta Ltd
- Samsung Medison
- United Imaging Healthcare
- Bracco Imaging S.p.A.
- Siemens Medical Solutions USA Inc.
- Toshiba Medical Systems Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 18.75 Billion |
| Forecasted Market Value ( USD | $ 27.02 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
